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White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Background: Magnetic resonance imaging indicates
diffuse white matter (WM) changes are associated with
cognitive impairment in cerebral autosomal dominant
arteriopathy with subcortical infarcts and leuko-
encephalopathy (CADASIL). We examined whether
the distribution of axonal abnormalities is related to
microvascular pathology in the underlying WM. Methods:
We used post-mortem brains from CADASIL subjects and
similar age cognitively normal controls to examine WM
axonal changes, microvascular pathology, and glial reac-
tion in up to 16 different regions extending rostro-caudally
through the cerebrum. Using unbiased stereological
methods, we estimated length densities of affected axons
immunostained with neurofilament antibody SMI32.
Standard immunohistochemistry was used to assess
amyloid precursor protein immunoreactivity per WM area.
To relate WM changes to microvascular pathology, we also
determined the sclerotic index (SI) in WM arterioles.
Results: The degree of WM pathology consistently scored
higher across all brain regions in CADASIL subjects
(P < 0.01) with the WM underlying the primary motor
cortex exhibiting the most severe change. SMI32 immuno-
reactive axons in CADASIL were invariably increased
compared with controls (P < 0.01), with most prominent
axonal abnormalities observed in the frontal WM
(P < 0.05).The SIs of arterioles in CADASIL were increased
by 25–45% throughout the regions assessed, with the
highest change in the mid-frontal region (P = 0.000).Con-
clusions: Our results suggest disruption of either cortico-
cortical or subcortical-cortical networks in the WM of the
frontal lobe that may explain motor deficits and executive
dysfunction in CADASIL. Widespread WM axonal changes
arise from differential stenosis and sclerosis of arterioles
in the WM of CADASIL subjects, possibly affecting
some axons of projection neurones connecting to targets
in the subcortical structures.
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Introduction
Cerebral autosomal dominant arteriopathy with sub-
cortical infarcts and leukoencephalopathy (CADASIL) is
the most common form of hereditary small vessel disease
(SVD), and is linked to mutations in the NOTCH3 gene
[1]. The clinical features in CADASIL are characterized
by recurrent strokes, migraine with aura, motor
deficits, pseudobulbar palsy, mood disturbances and
subcortical dementia [1]. The profile of cognitive impair-
ment in CADASIL resembles that in sporadic vascular cog-
nitive impairment (VCI), and manifests as deficits in
attention, processing speed and executive function, but
relatively preserved semantic fluency [2]. CADASIL sub-
jects exhibit rather specific spatial distribution of white
matter (WM) changes as shown by magnetic resonance
imaging (MRI) suggesting disrupted cortical connectivity
underlies the cognitive deficits. Abnormalities in normal-
appearing WM are not readily demonstrable with
conventional MRI, but become visible with diffusion
tensor imaging (DTI) or magnetization transfer imaging.
However, WM hyperintensities on normal MRI did not cor-
relate with cognitive dysfunction in CADASIL [3]. In con-
trast, DTI was shown to relate to impairment in executive
function in SVD as well as CADASIL [4,5]. Furthermore,
DTI histogram metrics were used to predict disease pro-
gression in CADASIL [6,7].
We have previously shown that WM changes are
reflected by severe demyelination, and are associated
with profound microvascular degeneration and enlarged
perivascular spaces in the temporal poles of CADASIL sub-
jects [8]. However, the extent of axonal abnormalities has
not been described in CADASIL and how this relates to the
underlying arteriopathy in the damaged WM is not clear.
Here, we performed a systematic pathological examina-
tion of the axonal integrity and microvascular changes
to provide insights into the vulnerable brain regions of
CADASIL subjects prior to death.
Materials and methods
Subjects
Table 1 provides the demographic details of the subjects.
The mean ages of the CADASIL and control subjects were
not different. Available case notes and radiological reports
indicated CADASIL subjects showed extensive WM
changes consistent with SVD of the brain and met the
minimum criteria for cognitive impairment used in our
post-stroke survivors study [9]. Duration of disease was
defined as the time between disease onset at first stroke
and death [10]. CADASIL diagnosis was confirmed by the
presence of NOTCH3 gene mutations or the presence of
granular osmiophilic material (GOM) in arteries within
Table 1. Demographic details of the CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy) subjects and controls
Group (n) Age (years) Gender Mutation
Duration
(years) Notable clinical features and risk factors
CAD1 44 F Arg153Cys 8 Cardiac arrhythmias
CAD2 53 F Arg133Cys 6 No vascular risk
CAD3 55 M Arg558Cys 11 Brief history of gout
CAD4 58 M Arg985Cys 13 No vascular risk
CAD5 59 M Arg169Cys 12 No vascular risk
CAD6 61 M Arg169Cys 10 Obesity (55 years –)
CAD7 66 F D239_D253del 23 No vascular risk, obesity
CAD8 68 F Arg133Cys 18 Smoking history
CAD9 68 M Arg153Cys 28 Smoking, prostate tumour
CAD10 52 M Arg141Cys 15 No vascular risk
CAD11 74 M Arg141Cys 12 No vascular risk
CADASIL (11) 58.8 ± 7.4 7M/4F – –
Controls (10) 65.7 ± 8.1 3M/7F – No significant cerebrovascular or
neurodegenerative disorder. No pathological diagnosis
The mini-mental state examination (MMSE) scores for the patients ranged from 12 to 21. Mean age of controls was not significantly different
from mean age of CADASIL group (P > 0.05). CADASIL cases used for SMI32 axonal analysis are designated as CAD1 to CAD9. Cases CAD10
and CAD11 were included in the sclerotic index, APP, GFAP and white matter score analysis.
F, female; M, male.
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skin biopsies [8]. None of the controls had neurological
or pathological evidence for cerebrovascular disease or
neurodegenerative disorder. We also endured that controls
did not have any evidence of cardiovascular disease in life
or at autopsy. Brain tissues from CADASIL subjects and
controls were collected from four sources. These were the
Newcastle Brain Tissue Resource, Newcastle General Hos-
pital; MRC London Brain Bank for Neurodegenerative Dis-
eases; the MRC Sudden Death Brain and Tissue Bank, the
University of Edinburgh and Ludwig Maximilians Univer-
sity, Germany. Use of brain tissue was approved by the
local research ethics committee of the Newcastle upon
Tyne Hospitals NHS Foundation Trust, the Newcastle
Brain Tissue Resource (NBTR) committee, and the ethics
committees overseeing the Brain Banks at the other
respective sites.
Neuropathological examination and quantitative
immunohistochemistry
Formalin fixed paraffin embedded coronal blocks from a
total of 16 brain regions (Table 2) were examined. These
extended along the rostro-caudal axis of the cerebrum,
per atlas of Perry and Oakley [11]. The blocks were
cut serially at either 30 μm thickness for the three-
dimensional stereology study, or at 10 μm thickness for
routine tinctorial staining and immunohistochemistry as
described previously [8]. Macroscopic and microscopic
pathology was assessed using standardized protocols as
described [12,13]. Haemotoxylin and eosin (H&E), luxol
fast blue (LFB) and cresyl fast violet (CFV) were used as
standard stains for describing neuropathological changes
and for detection of infarcts, presence of WM rarefac-
tion and extent of arteriopathy. Cerebrovascular lesions
including SVD pathology were assessed using a grading
system as described previously [13]. WM pathology was
scored on a scale of 0–3 with 0 = normal, 1 = mild,
2 = moderate and 3 = severe. Vascular scores were not sig-
nificantly different between the two operators (LC and
RNK) with over 90% agreement. The mean of the two sets
of scores was used in the final analysis.
For SMI32 immunohistochemistry, tissue sections
were first immunostained with a mouse anti-
nonphosphorylated neurofilament H (anti-SMI32,
Covance, CA, USA; 1:500) antibody. The sections were
then counterstained with 0.1% CFV to reveal the
total cell population (Figure 1). SMI32 is a 200 kDa
nonphosphorylated neurofilament protein, expressed in
large pyramidal projecting neurones and most abun-
dantly found in the long association pathways connecting
the cerebral lobes [14]. It is proposed to be a useful
indicator of long-term axonal degeneration [15] such
that chronically damaged axons exhibit accumulation of
SMI32 immunoreactivity [16].
For further immunohistochemical assessments, the fol-
lowing antibodies were used: mouse anti-amyloid precur-
sor protein clone 22C11 (APP, Millipore, Billerica, MA,
USA; 1:2000), rabbit anti-glial fibrillary acid protein
Table 2. Approximate Brodmann areas (BA) corresponding to underlying white matter regions
Block Coronal level* Anatomical area
A 4/5 Pre-frontal superior BA 9/46/32
B 8/9 Mid-frontal superior BA 9/8, cingulate BA 24/32 & deep white matter
C 9/10 Cingulate BA 24/32
G 16/17 Trans/entorhinal BA 27/28, OTG BA36 & dentate fascia
K 24 Parietal lateral BA40/22 & deep white matter
R 4/5 Pre-frontal superior half BA 46/45/47/11/32
S 6/7 Frontal lobe BA 8/9//46/45/47/11/12/32/24
Z 14/15 Motor BA 4, pre-motor BA6, cingulate BA 24 & deep white matter
AA 14/15 Temporal BA 20/21/22
AD 18/19 Motor BA 4, sensory BA 3/1/2/5/40 & cingulate BA23/31 & deep white matter
AE 20 Motor BA 4, cingulate BA 23/31 & deep white matter
AG 20 Hippocampus & temporal BA 27/28/35/36/20/21/22/41/42
AI 24 Parietal medial BA7a, cingulate BA23/31 & deep white matter
AJ 24 Parietal inferior BA 17/30/36/19/37/20/21
AK 26 Parieto-occipital lobes BA 7b/39/40/22/21/20/37/19/18/17/31
L 30 Occipital inferior BA17/18/19
*The table interprets which coronal blocks represent the Brodmann areas according to the Newcastle Brain Map [11].
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(GFAP, Dako Cytomation, Glostrup, Denmark; 1:8000)
and mouse anti-CD68 (1:200, Dako Cytomation). Unless
otherwise specified, sections stained with all other anti-
bodies were counterstained with Haematoxylin. Immuno-
histochemical staining of different markers was quantified
using the per cent area or the region of interest (ROI)
method using Image Pro Plus (V.4.0; Media Cybernetics,
Silver Spring, MD, USA). For sections stained with GFAP, a
grid of 0.5 mm2 area was placed over the ROI and the
number of cell bodies stained with GFAP was counted
from 10 images per ROI.
For additional evidence of axonal damage that comple-
ments SMI32 immunoreactivity findings, a subset of sec-
tions taken from the regions which scored high and low
and indicating large differences between controls and
CADASIL cases were immunostained for APP. The degree
of accumulated APP was defined by a five point scale as
follows: 1 = no staining, 2 = single swollen axons were
visible but no punctate deposits, 3 = appearance of punc-
tate deposits within normal appearing WM, 4 = multiple
larger areas of punctate deposits and 5 = confluent areas
of damaged WM with large areas of multiple APP-stained
swollen axons and punctate deposits.
For sclerotic index (SI) analysis and assessment of WM
damage, adjacent sections for those used for anti-SMI32
analysis were cut to 10μm thickness and stained with
H&E. The SI of microvessels within the WM was essen-
tially determined as described previously [17]. We ana-
lysed subcortical and deep WM across the four cortical
lobes as specified in the results (Table 2). SI values of
greater than 0.3 are considered to be a state of mild SVD,
and those greater than 0.5 are considered to be severe
[18]. All arterioles with external diameters between 35
and 350 μm within the region of interest were imaged
using a Zeiss Axioplan 2 microscope and Image capture
software (Infinity Capture V4.6.0, Lumenera Corporation,
Ottawa, Canada).
There were no apparent relationships between the
density of immunostaining and length of fixation, or post-
mortem interval from death to fixation of tissue between
the groups. All of the histopathological analyses were per-
formed blind to the operator.
Figure 1. Length density estimation using the space balls method. Hemispherical probes were placed at the centre of tissue thickness. The
radius of the probe was set to 12 μm taking the tissue shrinkage and guard volume into consideration. At each sampling point, the sampling
depth was scanned through and the intersections between the hemispherical probes (seen as a circle on the screen) and the SMI32 axons in
focus (marked with x) were counted. The length density was calculated by dividing the total axonal length by the sampled reference volume.
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Unbiased quantification of axonal changes
We used unbiased stereological methods to assess length
density of axons revealed by SMI32 immunoreactivity.
Immunostained sections were viewed under an Olympus
BX51 upright microscope coupled with MBF Bioscience
CX9000 camera, and length density of staining was ana-
lysed with StereoInvestigator (MBF Bioscience, VT, USA)
using a spherical probe (Figure 1). The XYZ motorized
stage was controlled by a Modular Automation Controller
6000 (Ludl Electronic Products Ltd, Hawthorne, NY, USA).
The sampling grid size was set to 902 × 751 μm to acquire
an average of 150–200 counts per ROI in a sample with
moderate axonal staining. At each sampling point, the
thickness of the tissue was measured using a Heidenhain
gauge, and the intersections between the hemispherical
probes and the SMI32 axons in focus were counted. The
length density, which is defined as total length of axons per
unit volume, was calculated by dividing the total axonal
length by the sampled reference volume.
Statistical analysis
Comparisons between markers such as SMI32 length
density in CADASIL and controls were made using
Kruskal–Wallis and Mann–Whitney U-tests incorporated
in SPSS version 17.0. WM scores and APP imm-
unoreactivity were further analysed using the independ-
ent samples K-Sample Median Test and Kruskal–Wallis
H-tests in SPSS V19.0. SI was analysed using independent
sample t-tests and two-way anova followed by Tukey’s test
post hoc in SPSS (IBM, New York, USA, v.19.0). GFAP cell
counts were tested for between region effects using anova,
and between group effects using t-tests for independent
samples. Relationships between axonal or pathological
markers, and demographic factors, were examined using
Spearman’s ρ (rho) correlation.
Results
Regional WM pathology in CADASIL
Neuropathological examination of the WM in coronal
tissue sections from CADASIL subjects revealed the typical
microvascular and parenchymal changes. The regional
differences in the degree of hyalinosis within arterioles
and presence of lacunar infarcts and microinfarcts were
readily apparent in CADASIL (Figure 2). Using our previ-
ous quantitative assessment methods [13], we observed
that the severity of WM pathology consistently scored
higher in CADASIL compared with controls (Table 3).
There were, however, pathological differences across
the brain regions in both CADASIL and control groups
(P < 0.01), where the WM generally underlying the
motor cortex (block Z) scored highly, signifying greater
WM damage. However, when WM scores were compared
between groups, there were differences between CADASIL
and controls in the A, B and K blocks (P < 0.05), and
trends in changes in the Z and AG blocks (P < 0.1), indi-
cating regions specifically affected by CADASIL. Spear-
man’s correlations showed that the degree of WM
pathology increased with duration of disease (rho 0.308,
P < 0.05).
Distribution of SMI32-positive axons and
APP immunoreactivity
Intense SMI32 immunostaining was observed throughout
the WM of CADASIL subjects compared with controls
(Figure 3). There was increased frequency of damaged
axons particularly in the WM underlying the frontal
cortex, BA4 and BA6 regions (Figure 4). In the same
regions, microinfarcts and markedly enlarged peri-
vascular spaces were also evident in two of the cases,
CAD1 and CAD11. Most surprising was the observation
that the highest SMI32 length density was found in the
WM at the coronal level of the primary motor cortex (AE
and AD), and premotor cortex (Z), in CADASIL subjects,
except for one case (CAD11). Thus suggesting that these
WM tracts are most vulnerable and undergo intense
pathological changes with CADASIL. A large number of
stained axons in these areas also showed increased thick-
ening compared with those in other regions. The largest
differences between CADASIL and controls were found
in the frontal lobe (areas S, B and Z; P = 0.029, 0.010
and 0.002 respectively), where controls had no SMI32-
positive axons. In addition, surprisingly the SMI32 axonal
length density in the temporal lobe (AG) was not as high
as in the WM regions close to motor areas, regions AE and
AD (Figure 4).
Features of axonal degeneration, such as swollen frag-
ments of axons and ‘retraction bulbs’, were found in areas
AG, K and AJ (Figure 3), which likely reduced the inter-
sections with probes and resulted in the lower length
density of SMI32 axons in these areas. The severity of the
abnormalities differed between some CADASIL cases.
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Figure 2. Histopathological features in the frontal and occipital lobes of a 68-year-old CADASIL (cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy) subject. Note more severe white matter (WM) changes and greater SMI32 and APP
immunoreactivities in the WM of the frontal lobe (motor) region (C, F, I) compared with the occipital region (B, E, H). A 55-year-old control
subject shows mild pathology in the occipital lobe (A, D, G). There were fewer activated microglial cells in controls (J) compared with
CADASIL subjects (K and L, occipital and frontal lobes respectively).
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CAD11 and CAD12, which had longer duration of disease
than CAD1 (Table 1), and correlations between SMI32
length density and disease length in these areas revealed
more changes in frontal and parietal lobes (B: rho = 0.811,
P = 0.050; Z: rho = 0.987, P = 0.001, AI: rho = 0.970,
P = 0.001 and AK: rho = 0.978, P = 0.022). There were
few changes in SMI32 immunoreactivity in the axons
within the corpus callosum in CADASIL subjects [19].
However, the severity of WM pathology was significantly
correlated with SMI32 length density (rho 0.517,
P < 0.001; Table 4).
We further quantified the staining patterns of another
marker of axonal change/damage across five brain
regions (Figure 2). Overall, axonal APP immunoreactivity
scored more highly in CADASIL cases compared with age-
matched controls (P = 0.014; K-Sample Median Test).
However, there were no significant differences in APP
staining between the subset of brain regions assessed
(P = 0.346; Kruskal–Wallis H-test) in CADASIL. When
comparing between CADASIL and controls regionally, we
only observed a trend for APP to score more highly in
CADASIL in the WM underlying the motor cortex
(P = 0.095, K-Sample Median Test). APP reactivity was
also correlated with WM pathology (rho 0.364, P < 0.01;
Table 4). Interestingly, APP was also increased with dura-
tion of disease (rho 0.687 P = 0.001).
We also immunostained sections with GFAP and CD68
antibodies to assess whether glial reactions were different
in the key regions with high SMI32 reactivity (Figure 2).
GFAP- labelled astrocytic cell counts were not found to be
different across brain regions either in control brains or in
CADASIL (P > 0.05; anova). There was also no significant
difference in GFAP cell counts between groups in any
region of the brain, although there was a trend for GFAP-
positive cells to be higher in CADASIL in the WM underly-
ing the motor cortex in block Z (P = 0.074). Microglial
immunostaining with antibodies to CD68 similarly
showed more activated cells in CADASIL (Figure 2) where
cells appeared rounder and engorged with material, but
there were no quantitative differences between groups or
across brain regions (P > 0.05, anova).
Distribution of microvascular pathology
In an attempt to relate the axonal changes to
microvascular pathology, SI values of arterioles were
determined in eight selected WM regions from all four
lobes of the brain (Figure 5). The mean SI value deter-
mined for CADASIL cases was 0.412 (SD 0.05) compared
with 0.306 (SD 0.04), in controls, corresponding to an
overall increase in CADASIL of 34.5% (P < 0.000, Inde-
pendent samples T-test). Two-way anova revealed signifi-
cant group differences (P = 0.000), but only a trend for
differences in SI between brain regions (P = 0.081), and
there was no interaction between groups and brain region
(P = 0.703). Post-hoc tests indicated that again the vessel
sclerosis in motor areas in block Z and the temporal lobe in
block AG, were different from the occipital lobe in block L
(P < 0.05, Tukey’s test), and showed a trend for differences
in the pre-frontal block B (P = 0.074).
The largest differences in vessel sclerosis between
CADASIL cases compared with controls were 45% and
44.0% in the pre-frontal block B and the occipital lobe in
block L respectively, whereas the lowest was in motor areas
in block Z and the parieto-occipital region block AK (27%
and 29% respectively, Figure 5). When considering the
average SIs of arterioles in eight regions across CADASIL
brains, our results showed the area with the most signifi-
cant level of arteriolosclerosis was in the WM underlying
the pre-frontal region in block B, with a mean SI of 0.45,
followed by the WM in the temporal lobe block AG. All
other regions had mean SI values of 0.40–0.41, except for
Table 3. White matter (WM) scores and sclerotic index values across brain regions
Block A B X Z AG K AK-2 L
Control WM score Median 1 1 1 2 1 1 1 1
Range 0–2 0–2 0–2 1–3 0–2 0–2 0–2 1–2
CADASIL Median 3 3 2 3 2 3 3 2
Range 1–3 1–3 2–3 2–3 1–2 2–3 1–3 1–2
Median WM scores as examined using 0–3 scale described in methods, range indicates minimum and maximum scores observed. The block
letters in top row correspond to the Brodmann areas (BA) as defined in Table 2, except values for AK-1 and AK-2 were pooled (no significant
differences).
CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
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the WM underlying occipital lobe in block L which showed
the least degree of arteriolosclerosis in CADASIL brains
(mean SI = 0.38), although it was increased by 44% com-
pared with vessels from the same region in controls. Cor-
relational analysis of the whole sample indicated that the
SI values were positively associated with the length densi-
ties of SMI32 (rho 0.346, P < 0.05). SI values of blood
vessels were also positively correlated with APP reactivity
(rho 0.283, P < 0.05) and WM pathology scores (rho
0.543, P < 0.001; Table 4).
Further analysis of each of the individual regions
showed strong positive association between SMI32 and SI
values in the WM underlying the mid-frontal region (rho
0.759, P = 0.035), and motor areas in block Z (rho 0.943,
P < 0.001). There were no correlations between the SI of
arterioles and SMI32 length density in the other regions
(data not shown). These results collectively confirmed
there is a relationship between axonal abnormalities and
microvascular pathologies in the WM of CADASIL
patients. However, there are also notable regional differ-
ences in the brain where the WM underlying the pre to
mid-frontal cortices have greater vulnerability to axon
damage.
Discussion
In this study, our most notable findings were the pathologi-
cal changes in the WM underlying the motor cortex, where
mean length density of SMI32, SI of arterioles, WM scores,
and APP immunoreactivity all indicated significant levels
Figure 4. Distribution and density of SMI32-positive axons. In
general, cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL) had more
axonal staining than controls especially in frontal lobes. The
density of abnormal axons correlated with disease duration (see
Table 4). Z-cc: corpus callosum area in block Z; ROI: region of
interest.
Figure 5. Degree of arteriolosclerosis across white matter (WM)
regions in CADASIL (cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy) and normal
age-matched control subjects. Points on graph show mean and
standard error (bars) of sclerotic index (SI) values in different brain
regions. The block letters on x axis correspond to the Brodmann
areas (BA) as defined in Table 2. The greatest increase in SI was
evident in WM underlying mid-frontal lobe (B block).
Table 4. Correlations between white matter (WM) pathology and markers of axonal damage
Spearman’s rho SMI32 n APP n WM score n GFAP count/0.5 mm2 n
SMI32
APP NS 23
WM score 0.517*** 40 0.364** 71
GFAP count/0.5 mm2 NS 22 −0.256* 68 NS 69
Sclerotic index 0.346* 40 0.283* 72 0.543*** 125 NS 69
Values show Spearman’s rho correlations for number (n) values analysed. Statistical significance was designated by following P values:
***P < 0.001; **P < 0.01; *P < 0.05.
Abbreviations: SMI32, nonphosphorylated neurofilament H length density; APP, amyloid precursor protein; GFAP count/0.5 mm2, glial
fibrillary acid protein cell count per 0.5 mm2; NS, not significant.
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of pathological damage in this region. This observation
is perhaps not surprising given the indications of motor
function abnormalities in CADASIL [6,20]. However,
the remarkable differential involvement of the brain WM
regions even in end-stage CADASIL subjects has not been
appreciated from pathological studies [8,10,21,22]. We
found differential levels of SMI32 staining across regions of
both control and CADASIL brains, where specific tracts
underlying the primary motor cortex [Brodmann Areas
(BA) 4/31] and premotor cortex (BA6) in both controls and
CADASIL had the most extensive axonal damage compared
with other regions. The WM tracts corresponding to the
temporal lobe regions did not reveal profoundly high
SMI32 immunoreactivity as would have been expected.
This lack of SMI32 reactivity in the temporal lobe further
supports the notion that WM hyperintensities observed in
the temporal lobe of CADSIL patients are due to enlarged
perivascular spaces and are not related to axonal patho-
genesis [8].
The most significant increase in axonal abnormalities
was detected in the frontal lobe, a region known to be
correlated with clinical and neuropsychological profile of
SVD-type dementia observed in CADASIL patients [2,23].
Our results also indicate that the blood vessels in the WM
of the frontal region underlying BAs 9/32 have the
highest degree of arteriopathy given the SI analysis. This
finding is consistent with also what we reported previ-
ously comparing the degrees of microvascular pathology
between the basal ganglia and the frontal region [10].
While our results advance our previous work on signifi-
cant degrees of arteriolosclerosis WM of the temporal
lobe, frontal and basal ganglia regions [8,10] we also
found consistent differential microvascular wall changes
across the subcortical WM underlying all four cortical
lobes. The correlations between SMI32 length density
and SI of vessels showed that there was not complete
congruence between the two variables in all regions, and
suggest differential disease mechanisms between axon
damage and vascular changes. There were robust corre-
lations between SMI32 length density and SI in the WM
underlying premotor and primary somatosensory corti-
ces, possibly indicating earlier involvement of these
regions in CADASIL disease progression.
As demonstrated with DTI, it is plausible that the SVD
type of changes to arterioles in CADASIL cause a chronic
hypoxic state within the deep WM resulting from cerebral
hypoperfusion [24,25]. This likely makes the WM more
vulnerable with increased demyelination in older age [26].
Given the greater degree of arteriolosclerosis in some WM
regions, such a sustained hypoxic state may occur earlier
with regional selectivity in CADASIL. However, it is
not clear whether axonal damage, as demonstrated by
increased SMI32 immunoreactivity, occurs in tandem or
secondary to demyelination. We had previously shown
that demyelination is associated with accumulation of
degraded myelin basic protein [8], which appears to be
also differentially distributed in the WM of CADASIL sub-
jects (LC and RNK, unpubl. obs.). Irrespective, our findings
support the selective vulnerability of the underlying WM,
in tandem with increased stenosis and sclerosis of arteri-
oles in the frontal lobe, as indicated here and implicated by
others [22]. Our observations are consistent with the fact
that the superior longitudinal fasciculus is the most
affected WM tract initially rather than the cingulum
bundle in CADASIL subjects [24].
The disconnection syndrome is a theory that cognitive
dysfunction can be, at least in part, attributed to disrupted
associative connections between various brain regions by
WM abnormality [27]. Tatsch et al. [28] have considered
disconnections by subcortical lesions as one of the causes
of reduced cortical metabolism and cognitive dysfunction
in CADASIL. This is consistent with the findings that
lacunar infarcts have been associated with cognitive dys-
function in CADASIL but not WM hyperintensities on T2
weighted MRI [3], which we have been shown to reflect
fluid accumulation in enlarged perivascular spaces rather
than WM loss [8].
A major limitation of our study is that we could not
perform robust clinicopathological correlations. We
utilized CADASIL brain tissues from several different
resources, which inevitably did not allow stringent corre-
lations with clinical features, neuroimaging findings
or neuropsychological or cognitive function test scores.
Establishing large prospective studies of CADASIL patients
followed up to autopsy by collaborating centres would
greatly facilitate studies on CADASIL as a model of VCI.
The regional variability in degrees of axonal damage as
revealed by SMI32 immunoreactivity suggests that early
changes occur in the frontal lobe with a gradual WM dis-
connection involving the parietal and temporal lobes. It is
not yet clear whether these pathological changes precede
neuronal atrophy or loss in CADASIL. However, consistent
with previous MRI studies on medial temporal lobe
atrophy in CADASIL subjects [29], in a parallel study we
had found SMI32-positive neuronal densities in CA1 and
CA2 regions of the hippocampus tended to be decreased
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by 30–40% in CADASIL subjects compared with similar
age controls (YY et al., unpubl. obs.). Collectively, these
observations concur with the previously reported vulner-
ability of the hippocampal pyramidal neurones [30]
in vascular dementia in poststroke survivors, indicating
there is as a vascular basis for neurodegeneration.
Our results and the previous DTI MRI studies support
the hypothesis that cognitive dysfunction in CADASIL is
attributable to the disconnection of cortico-cortical or
subcortical-cortical networks particularly in the frontal
rather than the temporal lobe. These observations have
wider implications for cerebral SVD in the elderly.
Acknowledgements
The authors are grateful to the patients and families for
their cooperation in the investigation of this study. We
thank Janet Y Slade and Roslyn Hall for expert technical
assistance. The authors acknowledge the MRC London
Brain Bank for Neurodegenerative Diseases (Dr Claire
Troakes), Institute for Stroke and Dementia Research,
Ludwig Maximilians University, Munich Germany (Prof.
Dr Martin Dichgans) and the MRC Sudden Death Brain
and Tissue Bank, the University of Edinburgh, for provid-
ing one each of the CADASIL cases and two control
cases respectively. Tissue for this study was also provided
by the Newcastle Brain Tissue Resource which is funded
in part by a grant from the UK Medical Research
Council (G1100540), by the Newcastle NIHR Biomedical
Research Centre in Ageing and Age Related Diseases to the
Newcastle upon Tyne Hospitals NHS Foundation Trust,
and by a grant from the Alzheimer’s Society and Alzhei-
mer’s Research Trust as part of the Brains for Dementia
Research Project.
Sources of funding
Enabled by funding from the Overseas Research
Studentship Awards, RCUK Newcastle Centre for Brain
Ageing and Vitality, the Medical Research Council (UK)
and BrainNet II Europe, Germany.
Author contributions
Lucinda J. L. Craggs: analysis and interpretation of data,
acquisition of the microvascular results and revising
the manuscript at various stages of preparation.
Yumi Yamamoto: acquisition of the original data, analysis
and interpretation of the results and, revising the
manuscript.
Masafumi Ihara: editing and revising the manuscript, and
interpretation of the analysis.
Richard Fenwick: analysis and acquisition of the original
SI data.
Matthew Burke: acquisition of original data.
Arthur Oakley: analysis/interpretation/acquisition of
data, technical advice on imaging and revising the
manuscript.
Sigrun Roeber: comments on the manuscript and diag-
nosing and storing the German cases.
Marco Duering: revising the manuscript and providing
clinical data on the cases.
Hans Kretzschmar: revising the manuscript, diagnosing
the cases and obtaining funding
Raj N. Kalaria: drafting, revising the manuscript and inter-
pretation of data, diagnosing the cases and obtaining
funding.
Disclosures
None related to this manuscript.
References
1 Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E,
Bousser M-G. CADASIL. Lancet Neurol 2009; 8: 643–53
2 Buffon F, Porcher R, Hernandez K, Kurtz A, Pointeau S,
Vahedi K, Bousser MG, Chabriat H. Cognitive profile
in CADASIL. J Neurol Neurosurg Psychiatry 2006; 77:
175–80
3 Viswanathan A, Gschwendtner A, Guichard JP, Buffon F,
Cumurciuc R, O’Sullivan M, Holtmannspötter M, Pachai
C, Bousser MG, Dichgans M, Chabriat H. Lacunar lesions
are independently associated with disability and cognitive
impairment in CADASIL. Neurology 2007; 69: 172–9
4 O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF,
Markus HS. MRI hyperintensities of the temporal lobe
and external capsule in patients with CADASIL. Neurol-
ogy 2001; 56: 628–34
5 O’Sullivan M, Singhal S, Charlton R, Markus HS. Diffu-
sion tensor imaging of thalamus correlates with cogni-
tion in CADASIL without dementia. Neurology 2004; 62:
702–7
6 Chabriat H, Pappata S, Poupon C, Clark CA, Vahedi K,
Poupon F, Mangin JF, Pachot-Clouard M, Jobert A,
Le Bihan D, Bousser M. Clinical severity in CADASIL
related to ultrastructural damage in white matter: in
vivo study with diffusion tensor MRI. Stroke 1999; 30:
2637–43
7 Holtmannspotter M, Peters N, Opherk C, Martin D,
Herzog J, Bruckmann H, Samann P, Gschwendtner A,
Dichgans M. Diffusion magnetic resonance histograms as
WM disconnection in CADASIL 601
NAN 2014; 40: 591–602© 2013 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd
on behalf of British Neuropathological Society
a surrogate marker and predictor of disease progression
in CADASIL: a two-year follow-up study. Stroke 2005; 36:
2559–65
8 Yamamoto Y, Ihara M, Tham C, Low WC, Slade JY,
Moss T, Oakley AE, Polvikoski T, Kalaria RN. Neuro-
pathological correlates of temporal pole white matter
hyperintensities in CADASIL. Stroke 2009; 40: 2004–
11
9 Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW,
Polvikoski TM, O’Brien JT, Kalaria RN. Long term inci-
dence of dementia, predictors of mortality and pathologi-
cal diagnosis in older stroke survivors. Brain 2011; 134:
3716–27
10 Craggs LJ, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson
A, Andersen O, Viitanen M, Kalimo H, McLean CA, Slade
JY, Hall RA, Oakley AE, Yamamoto Y, Deramecourt
V, Kalaria RN. Quantitative vascular pathology and
phenotyping familial and sporadic cerebral small vessel
diseases. Brain Pathol 2013. doi:10.1111/bpa.12041
11 Perry RH, Oakley AE. Newcastle Brain Map. London:
Wolfe, 1993
12 Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P,
Polvikoski T. Towards defining the neuropathological
substrates of vascular dementia. J Neurol Sci 2004; 226:
75–80
13 Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG,
Maurage CA, Kalaria RN. Staging and natural history of
cerebrovascular pathology in dementia. Neurology 2012;
78: 1043–50
14 Hof PR, Nimchinsky EA, Morrison JH. Neurochemical
phenotype of corticocortical connections in the macaque
monkey: quantitative analysis of a subset of neuro-
filament protein-immunoreactive projection neurons in
frontal, parietal, temporal, and cingulate cortices. J Comp
Neurol 1995; 362: 109–33
15 Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M.
Chronic toxic demyelination in the central nervous
system leads to axonal damage despite remyelination.
Neurosci Lett 2009; 453: 120–5
16 Voelker CC, Garin N, Taylor JS, Gahwiler BH, Hornung JP,
Molnar Z. Selective neurofilament (SMI-32, FNP-7 and
N200) expression in subpopulations of layer V pyramidal
neurons in vivo and in vitro. Cereb Cortex 2004; 14:
1276–86
17 Yamamoto Y. Density of Microvascular Components in Cer-
ebral Autosomal Dominant Arteriopathy with Subcortical
Infarcts and Leukoencephalopathy. Newcastle upon Tyne:
Medical Sciences, Newcastle University, 2006
18 Lammie GA, Brannan F, Slattery J, Warlow C.
Nonhypertensive cerebral small-vessel disease: an auto-
psy study. Stroke 1997; 28: 2222–9
19 Coulthard A, Blank SC, Bushby K, Kalaria RN, Burn DJ.
Distribution of cranial MRI abnormalities in patients
with symptomatic and subclinical CADASIL. Br J Radiol
2000; 73: 256–65
20 Manganelli F, Ragno M, Cacchiò G, Iodice V, Trojano L,
Silvaggio F, Scarcella M, Grazioli M, Santoro L, Perretti A.
Motor cortex cholinergic dysfunction in CADASIL: a
transcranial magnetic demonstration. Clin Neurophysiol
2008; 119: 351–5
21 Miao Q, Paloneva T, Tuisku S, Roine S, Poyhonen M,
Viitanen M, Kalimo H. Arterioles of the lenticular
nucleus in CADASIL. Stroke 2006; 37: 2242–7
22 Miao Q, Paloneva T, Tuominen S, Poyhonen M, Tuisku S,
Viitanen M, Kalimo H. Fibrosis and stenosis of the long
penetrating cerebral arteries: the cause of the white
matter pathology in cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoen-
cephalopathy. Brain Pathol 2004; 14: 358–64
23 Peters N, Opherk C, Danek A, Ballard C, Herzog J,
Dichgans M. The pattern of cognitive performance in
CADASIL: a monogenic condition leading to subcortical
ischemic vascular dementia. Am J Psychiatry 2005; 162:
2078–85
24 O’Sullivan M, Barrick TR, Morris RG, Clark CA, Markus
HS. Damage within a network of white matter regions
underlies executive dysfunction in CADASIL. Neurology
2005; 65: 1584–90
25 Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis
CE, Barber R, Kalaria RN, Forster G, Esteves F, Wharton
SB, Shaw PJ, O’Brien J, Ince PG. White matter lesions in
an unselected cohort of the elderly: molecular pathology
suggests origin from chronic hypoperfusion injury. Stroke
2006; 37: 1391–8
26 Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH,
Oakley AE, Englund E, O’Brien JT, Ince PG, Kalaria RN.
Quantification of myelin loss in frontal lobe white matter
in vascular dementia, Alzheimer’s disease, and dementia
with Lewy bodies. Acta Neuropathol 2010; 119: 579–89
27 Catani M, Ffytche DH. The rises and falls of disconnection
syndromes. Brain 2005; 128: 2224–39
28 Tatsch K, Koch W, Linke R, Poepperl G, Peters N,
Holtmannspoetter M, Dichgans M. Cortical hypo-
metabolism and crossed cerebellar diaschisis suggest
subcortically induced disconnection in CADASIL: an 18F-
FDG PET study. J Nucl Med 2003; 44: 862–9
29 O’Sullivan M, Ngo E, Viswanathan A, Jouvent E,
Gschwendtner A, Saemann PG, Duering M, Pachai C,
Bousser M-G, Chabriat H, Dichgans M. Hippocampal
volume is an independent predictor of cognitive perfor-
mance in CADASIL. Neurobiol Aging 2009; 30: 890–7
30 Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar
A, Oakley AE, Deramecourt V, Polvikoski TM, O’Brien JT,
Kalaria RN. Hippocampal neuronal atrophy and cogni-
tive function in delayed poststroke and aging-related
dementias. Stroke 2012; 43: 808–14
Received 9 January 2013
Accepted after revision 4 July 2013
Published online Article Accepted on 12 July 2013
602 L. J. L. Craggs et al.
NAN 2014; 40: 591–602© 2013 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd
on behalf of British Neuropathological Society
